Ceregene's Series D Round

Ceregene raised a round of funding on November 12, 2010.

Ceregene is a San Diego-based biotechnology company focused on the development of nervous system growth factors (neurotrophic factors) as treatments for neurodegenerative and retinal disorders using g…

Articles about Ceregene's Series D Round: